HomeDai laboratori di Nerviano Medical Sciences nuovi dati presentati all’AACR meeting di Philadelphia

Dai laboratori di Nerviano Medical Sciences nuovi dati presentati all’AACR meeting di Philadelphia

Nerviano, 18.03.2015

All’appuntamento annuale dell’American Association for Cancer Research (AACR) che si svolgerà ad aprile, Nerviano Medical Sciences presenterà nuove evidenze dalle attività di ricerca condotte sui cordomi e su nuovi diversi inibitori.

Di seguito i dettagli degli abstract (disponibili al sito http://www.aacr.org) e dell’oral presentation prevista per lunedì 20:

Presentation title: Establishment and characterization of the new sacral chordoma cell line Chor-IN-1
Authors: Paola Magnaghi et al
Meeting: AACR Annual Meeting 2015, Abstract number 74
Presentation Time: Sunday, Apr 19, 2015, 1:00 PM - 5:00 PM

Presentation Title: NMS-P088, a dual FLT3-KIT inhibitor active also on gatekeeper mutations and devoid of QTc prolongation
Authors: Ciomei, M et al
Meeting: AACR Annual Meeting 2015, Abstract number 798
Presentation Time: Sunday, Apr 19, 2015, 1:00 PM - 5:00 PM

Presentation title: Preclinical characterization of the novel TTK kinase inhibitor S81694 for the treatment of triple negative breast cancer
Authors: Riccardo Colombo et al
Meeting: AACR Annual Meeting 2015, Abstract number 1638
Presentation Time: Monday, Apr 20, 2015, 8:00 AM -12:00 PM

Presentation title: Preclinical characterization of NMS-P648, a novel and potent PARP-1/-3 inhibitor
Authors: Alessia Montagnoli et al
Meeting: AACR Annual Meeting 2015, Abstract number 2851
Presentation Time: Monday, Apr 20, 2015, 3:50 PM - 4:05 PM

The last poster has been selected for an oral presentation:
Session title: PARP and DNA Repair Inhibitors
Session type: Minisymposium
Session Start/End Time: Monday, Apr 20, 2015, 3:00 PM - 5:00 PM
Location: Room 108, Pennsylvania Convention Center